eanNews - Page 104 of 288 - Stay up to date with Neurology in Europe

- Executive Page: Multiple Opportunities to Serve & Support EAN & Neurology
  
  March 12, 2026
- President’s Corner – March 2026
  
  March 10, 2026
- Research Paper of the Month: Coffee and Tea Intake, Dementia Risk, and Cognitive Function
  
  March 2, 2026
- Executive Page: Building an Academic Path for Neurologists in Europe
  
  February 11, 2026
- President’s Corner – February 2026
  
  February 11, 2026
- Research Paper of the Month: Fremanezumab in Children and Adolescents with Episodic Migraine
  
  February 11, 2026

Top Articles

Calls for Coordinated Action on Brain Health in European Parliament on Brain Health Day

March 18, 2026

The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.

World’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain

March 6, 2026

12th Congress of the European Academy of Neurology celebrates with main headline that abstract submissions have hit record high!

EAN 2026 Hits New All-Time Abstract Submission Record

February 13, 2026

European Brain Health Summit 2026: Building the Foundation for a Brain-Healthy Society and Economy

February 12, 2026

Brain Health Day in white text on a blue-green gradient background

Join us for Brain Health Day: Prevention, Policy, Progress

February 11, 2026

Latest Posts

Breaking news COVID-19 Research
Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study

April 1, 2021

Impact of the COVID‐19 pandemic and a national lockdown on hospitalisation for stroke and related 30‐day mortality in France: a nationwide observational study
Breaking news COVID-19 Research
Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis

April 1, 2021

Outcomes and risk factors associated with SARS-CoV-2 infection in a north American registry of patients with multiple sclerosis
Breaking news COVID-19 Research
Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature

April 1, 2021

Acute transverse myelitis with dysautonomia following SARS-CoV-2 infection: a case report and review of literature
Breaking news COVID-19 Research
Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study

April 1, 2021

Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study
Breaking news COVID-19 Research
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

April 1, 2021

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network
Breaking news COVID-19 Research
Brain and lung imaging correlation in patients with COVID-19: could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? a global multicenter observational Study

April 1, 2021

Brain and lung imaging correlation in patients with COVID-19: could the severity of lung disease reflect the prevalence of acute abnormalities on neuroimaging? a global multicenter observational Study
Breaking news COVID-19 Research
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis

April 1, 2021

Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis
Breaking news COVID-19 Research
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs

April 1, 2021

Vaccinations in multiple sclerosis patients receiving disease-modifying drugs
Breaking news COVID-19 Research
Is the Frontal Lobe the Primary Target of SARS-CoV-2?

April 1, 2021

Is the Frontal Lobe the Primary Target of SARS-CoV-2 ?
Breaking news COVID-19 Research
Acute ischemic stroke in patients with COVID-19: an analysis from Get With The Guidelines-Stroke

April 1, 2021

Acute ischemic stroke in patients with COVID-19: an analysis from Get With The Guidelines-Stroke
Breaking news COVID-19 Research
Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study

April 1, 2021

Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study
Breaking news COVID-19 Research
Brainstem clinical and neurophysiological involvement in COVID-19

April 1, 2021

Brainstem clinical and neurophysiological involvement in COVID-19
Breaking news COVID-19 Research
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

April 1, 2021

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Breaking news COVID-19 Research
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

April 1, 2021

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Breaking news COVID-19 Research
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

April 1, 2021

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Newer Posts

Older Posts